Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: J Trauma Acute Care Surg. 2022 Jan 1;92(1):159–166. doi: 10.1097/TA.0000000000003410

Figure 3.

Figure 3.

Proposed schema of the a-globin augmentation of plasmin activity. Plasminogen (PLG) circulates in a reversible complex with histidine rich glycoprotein (HRG), which is a competitive inhibitor, which can encounter the α-globin chain of hemoglobin (α-globin). In response to fibrin endothelial cells release tissue plasminogen activator (tPA) which than activated plasminogen, which is bound to the α-globin chain, and causes increased plasmin activity.